A gene therapy for haemophilia – from the lab to the patient

30 November 2022

Richard Fagan and Amit Nathwani

At our Winter Showcase event on 16 November 2022, we highlighted some of our recent successes in translating research conducted at UCL into technologies and innovations that have a real and positive impact on individuals and society as a whole.

Dr Richard Fagan (UCLB’s Director of BioPharm) and Professor Amit Nathwani, Professor of Immunology at UCL, gave a fascinating insight into how Professor Nathwani’s research is being translated into treatments for patients.

Read the full article from Bristows.